Page last updated: 2024-11-08

d-tagatose 1,6-diphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID189150
CHEMBL ID1235115
CHEBI ID49093
SCHEMBL ID328998
MeSH IDM0087276

Synonyms (16)

Synonym
CHEMBL1235115
keto-d-tagatose 1,6-bisphosphate
CHEBI:49093 ,
1,6-di-o-phosphono-d-tagatose
keto-d-tagatose 1,6-bis(dihydrogen phosphate)
DB02512
p6t ,
55529-38-9
tagatose 1,6-diphosphate
d-tagatose 1,6-diphosphate
d-tagatose 1,6-bis(dihydrogen phosphate)
SCHEMBL328998
DTXSID30204099
hexosediphosphat
Q27093497
PD007907
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
D-tagatose 1,6-bisphosphateA ketohexose bisphosphate that is D-tagatose carrying phosphate groups at positions 1 and 6.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1419069Inhibition of rabbit muscle fructose-bisphosphate aldolase using FBP as substrate and NADH by spectrophotometry based coupled enzyme assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Bisphosphonate Inhibitors of Mammalian Glycolytic Aldolase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (30.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.35 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]